Empirical Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Sell
15,535
-1,000
-6% -$117K 0.45% 54
2026
Q1
$1.99M Buy
16,535
+4,054
+32% +$468K 0.52% 34
2025
Q4
$1.02M Sell
12,481
-222
-2% -$20.8K 0.29% 92
2025
Q3
$834K Buy
12,703
+898
+8% +$74K 0.23% 133
2025
Q2
$934K Buy
11,805
+1,857
+19% +$148K 0.29% 94
2025
Q1
$893K Buy
9,948
+5,419
+120% +$506K 0.3% 88
2024
Q4
$451K Sell
4,529
-21,352
-83% -$2.2M 0.15% 175
2024
Q3
$493K Buy
25,881
+558
+2% +$66.3K 0.18% 168
2024
Q2
$467K Buy
25,323
+23,592
+1,363% +$3.04M 0.18% 171
2024
Q1
$228K Buy
+1,731
New +$213K 0.11% 242

Other funds holding MRK

Empirical Asset Management's MRK Position: Q2 2026 in Review

Empirical Asset Management reduced its Merck (MRK) stake by 6% in Q2 2026, selling an estimated $117K and leaving 15,535 shares worth $2M. The position accounts for 0.45% of the portfolio, ranked #54.

Empirical Asset Management first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Empirical Asset Management held 15,535 shares of Merck worth $2M as of Q2 2026.
  • Empirical Asset Management sold 1,000 Merck shares in Q2 2026, an estimated $117K.
  • Merck made up 0.45% of Empirical Asset Management's portfolio in Q2 2026, its #54 holding.
  • Empirical Asset Management first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.